Key result
Urapidil is an effective and well-tolerated antihypertensive medication for treating acute elevation of blood pressure, with additional benefits for pulmonary artery BP and bronchial conductivity.
Why the study?
Does urapidil effectively and safely reduce blood pressure in patients with acute elevation of blood pressure?
Does urapidil effectively and safely reduce blood pressure in patients with acute elevation of blood pressure?
This review highlights urapidil as an effective and safe option for managing acute blood pressure elevations, with added pulmonary and bronchial benefits.
Answers are grounded in this paper and cite their sources.
May support urapidil consideration in acute hypertension; leaves open randomized confirmation of pulmonary benefits.
The paper reviews the clinical practice potential of a combined action antihypertensive medication urapidil for the treatment of patients with acute elevation of blood pressure (BP) and confirms urapidil effectiveness and good tolerability. Urapidil action mechanisms, pharmacodynamics, and pharmacokinetics are discussed, together with the results of the key clinical trials which have demonstrated antihypertensive effectiveness and safety of this agent. Additional beneficial effects of urapidil, such as reduction of the increased pulmonary artery BP and improvement of bronchial conductivity, are also described.
No takes yet. Share an insight, caveat, or question.
Гапонова et al. (2014) conducted a review in Acute elevation of blood pressure. Urapidil was evaluated. Urapidil is an effective and well-tolerated antihypertensive medication for treating acute elevation of blood pressure, with additional benefits for pulmonary artery BP and bronchial conductivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: